Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natasha K Martin, DPhil"'
Autor:
Charles Marks, MPH, Daniela Abramovitz, MS, Christl A Donnelly, ProfScD, Gabriel Carrasco-Escobar, MS, Rocío Carrasco-Hernández, PhD, Daniel Ciccarone, ProfMD, Arturo González-Izquierdo, PhD, Natasha K Martin, DPhil, Steffanie A Strathdee, ProfPhD, Davey M Smith, ProfMD, Annick Bórquez, PhD
Publikováno v:
The Lancet Public Health, Vol 6, Iss 10, Pp e720-e728 (2021)
Summary: Background: The emergence of fentanyl around 2013 represented a new, deadly stage of the opioid epidemic in the USA. We aimed to develop a statistical regression approach to identify counties at the highest risk of high overdose mortality in
Externí odkaz:
https://doaj.org/article/292dfef255a543309b5c9d8e780b4078
Autor:
Aaron G Lim, DPhil, Josephine G Walker, PhD, Nyashadzaishe Mafirakureva, PhD, Gul Ghuttai Khalid, MPH, Huma Qureshi, FRCP, Hassan Mahmood, FRSPH, Adam Trickey, PhD, Hannah Fraser, PhD, Khawar Aslam, MBBS, Gregoire Falq, MPH, Camille Fortas, MPH, Hassaan Zahid, MBBS, Ammara Naveed, MBBS, Rosa Auat, MD, Quaid Saeed, MPH, Charlotte F Davies, PhD, Christinah Mukandavire, PhD, Nancy Glass, MPH, David Maman, MD, Natasha K Martin, DPhil, Matthew Hickman, ProfPhD, Margaret T May, ProfPhD, Saeed Hamid, ProfFRCP, Anne Loarec, MD, Francisco Averhoff, MD, Peter Vickerman, ProfDPhil
Publikováno v:
The Lancet Global Health, Vol 8, Iss 3, Pp e440-e450 (2020)
Summary: Background: The WHO elimination strategy for hepatitis C virus advocates scaling up screening and treatment to reduce global hepatitis C incidence by 80% by 2030, but little is known about how this reduction could be achieved and the costs o
Externí odkaz:
https://doaj.org/article/52e9e7abd86245788c40fc6ac95606e9
Autor:
Josephine G Walker, PhD, Tinatin Kuchuloria, MD, David Sergeenko, MD, Hannah Fraser, PhD, Aaron G Lim, DPhil, Shaun Shadaker, MPH, Liesl Hagan, MPH, Amiran Gamkrelidze, ProfPhD, Valeri Kvaratskhelia, MD, Lia Gvinjilia, MD, Malvina Aladashvili, MD, Alexander Asatiani, MD, Davit Baliashvili, MD, Maia Butsashvili, ProfPhD, Ivdity Chikovani, MD, Irma Khonelidze, MD, Irma Kirtadze, PhD, Mark H Kuniholm, PhD, David Otiashvili, PhD, Lali Sharvadze, PhD, Ketevan Stvilia, MD, Tengiz Tsertsvadze, ProfPhD, Mamuka Zakalashvili, MD, Matthew Hickman, PhD, Natasha K Martin, DPhil, Juliette Morgan, MD, Muazzam Nasrullah, PhD, Francisco Averhoff, MD, Peter Vickerman, ProfDPhil
Publikováno v:
The Lancet Global Health, Vol 8, Iss 2, Pp e244-e253 (2020)
Summary: Background: Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up tr
Externí odkaz:
https://doaj.org/article/3bc3fb73a00649c1884f1f75f9adb138
Autor:
Annick Borquez, PhD, Leo Beletsky, JD, Bohdan Nosyk, PhD, Steffanie A Strathdee, ProfPhD, Alejandro Madrazo, ProfJSD, Daniela Abramovitz, MS, Claudia Rafful, PhD, Mario Morales, MA, Javier Cepeda, PhD, Dimitra Panagiotoglou, PhD, Emanuel Krebs, MA, Peter Vickerman, ProfDPhil, Marie Claude Boily, ProfPhD, Nicholas Thomson, PhD, Natasha K Martin, DPhil
Publikováno v:
The Lancet Public Health, Vol 3, Iss 9, Pp e429-e437 (2018)
Summary: Background: As countries embark on public health-oriented drug law reform, health impact evaluations are needed. In 2012, Mexico mandated the narcomenudeo reform, which depenalised the possession of small amounts of drugs and instituted drug
Externí odkaz:
https://doaj.org/article/731b33fa1c98473da7ffc52748daa67b
Autor:
Jeffrey W Eaton, PhD, Nicolas A Menzies, MPH, John Stover, MA, Valentina Cambiano, MS, Leonid Chindelevitch, PhD, Anne Cori, PhD, Jan A C Hontelez, PhD, Salal Humair, PhD, Cliff C Kerr, PhD, Daniel J Klein, PhD, Sharmistha Mishra, MD, Kate M Mitchell, PhD, Brooke E Nichols, MS, Prof. Peter Vickerman, DPhil, Roel Bakker, PhD, Till Bärnighausen, DSc, Anna Bershteyn, PhD, Prof. David E Bloom, PhD, Marie-Claude Boily, PhD, Stewart T Chang, PhD, Ted Cohen, DPH, Peter J Dodd, PhD, Prof. Christophe Fraser, PhD, Chaitra Gopalappa, PhD, Prof. Jens Lundgren, DMSc, Natasha K Martin, DPhil, Evelinn Mikkelsen, MSc, Elisa Mountain, MSc, Quang D Pham, MD, Michael Pickles, PhD, Prof. Andrew Phillips, PhD, Lucy Platt, PhD, Carel Pretorius, PhD, Holly J Prudden, MSc, Prof. Joshua A Salomon, PhD, David A M C van de Vijver, PhD, Sake J de Vlas, PhD, Bradley G Wagner, PhD, Richard G White, PhD, David P Wilson, PhD, Lei Zhang, PhD, John Blandford, PhD, Gesine Meyer-Rath, PhD, Michelle Remme, MSc, Paul Revill, PhD, Nalinee Sangrujee, PhD, Fern Terris-Prestholt, PhD, Meg Doherty, PhD, Nathan Shaffer, MD, Prof. Philippa J Easterbrook, MD, Gottfried Hirnschall, MD, Prof. Timothy B Hallett, PhD
Publikováno v:
The Lancet Global Health, Vol 2, Iss 1, Pp e23-e34 (2014)
Background: New WHO guidelines recommend initiation of antiretroviral therapy for HIV-positive adults with CD4 counts of 500 cells per μL or less, a higher threshold than was previously recommended. Country decision makers have to decide whether to
Externí odkaz:
https://doaj.org/article/9bd6c2f8c1b9479a8165b343ebb7c4e9